Authored By: Sarah
20 Nov 2024

increasing prevalence of allergies is driving the Epinephrine Autoinjector Market

Latest News:- Epinephrine Autoinjector Market: 0.30gm is expected to lead the Type segment during 2024-2028

Technavio analyzes that the Epinephrine Autoinjector Market is expected to grow at a CAGR of 10.59% during 2023 and 2028. During this period, the market is also expected to show a growth of USD 2.44 billion.There are various factors that contribute to the growth of the market. The Epinephrine Autoinjector market is experiencing significant growth due to the rising prevalence of allergies worldwide. Allergic conditions, such as anaphylaxis, are increasingly common, leading to a greater demand for these life-saving devices. Epinephrine autoinjectors are essential medical tools that enable individuals with allergies to self-administer a dose of epinephrine during an allergic reaction, thereby preventing potential fatalities. The market is expected to continue its upward trend as the number of allergy sufferers increases, and awareness about the importance of carrying an epinephrine autoinjector grows.

The global epinephrine autoinjector market, specifically the 0.30gm dosage segment, is experiencing significant growth due to increasing sales of generic alternatives, such as Amneal Pharmaceuticals' Adrenaclick. This growth is attributed to the price hikes of leading brands like Viatris' EpiPen in the US market, which has created an opportunity for generic manufacturers. In Europe, where multiple brands are available, Viatris' market share may decline, potentially hindering growth. Furthermore, researchers and emerging companies are focusing on developing alternatives to EpiPen due to periodic competitor exits and gradual price increases from Viatris. 

Know which region is leading the market growth by requesting a sample report

Epinephrine Autoinjector Market Segmentation

  • Type
    • 0.30gm
    • 0.15gm
    • 0.50gm
  • End-user
    • Hospitals
    • clinics
    • Homecare
  • Geography
    • North America
    • Europe
    • Asia
    • Rest of World (ROW)

Top Performing Companies

As per our research findings, here are some of the key competitors that are leading the industry

  • Adamis Pharmaceuticals Corp.
  • ALK Abello AS
  • Amneal Pharmaceuticals Inc.
  • Bausch Health Companies Inc.
  • BIOPROJET
  • Crossject
  • Halozyme Therapeutics Inc.
  • kaleo Inc.
  • Pfizer Inc.
  • Teva Pharmaceutical Industries Ltd.
  • Viatris Inc.

Find out what is trending in the market by accessing the free PDF report

Research Analysis Overview

The Epinephrine Autoinjector market encompasses handheld devices like epinephrine pens and epipens, which deliver essential doses of epinephrine, also known as adrenaline, to individuals experiencing acute anaphylactic reactions due to allergic diseases, insect bites, or stings. These autoinjectors are crucial for severe allergic responses and are increasingly accepted by healthcare professionals and consumers. Companies like Amphastar Pharmaceuticals produce both branded and generic epinephrine autoinjectors, offering innovative needle-free injector technologies to cater to various age groups.

Market Research Overview

The Epinephrine Autoinjector market is a significant segment within the larger Global Healthcare Equipment Market, according to Technavio's market research. This market category encompasses businesses involved in the research and development (R&D), manufacturing, and distribution of epinephrine autoinjectors, which are essential medical devices used to treat acute anaphylactic reactions in various age groups suffering from allergic diseases. These injections are classified as consumables within the healthcare equipment industry, contributing to the overall market size, which includes the combined revenue generated by manufacturers of diagnostic equipment and devices across diverse therapy areas.. Industries are leveraging the products belonging to the market for customer engagement, transactional notifications, and promotional offers.

Reasons to Consider Purchasing Technavio Market Research Report

  • Current Market Insights: Our reports offer valuable information on the latest market intelligence, competitor strategies, trends, industry changes, customer preferences, and forecasted market opportunities to aid in informed business decisions.

  • Extensive Experience: With over 20 years in market research, Technavio is a trusted name, having published more than 21,000 reports across various industries and regions.

  • High ROI Through In-Depth Research: Technavio specializes in tailored market research reports to meet specific business needs, exploring particular markets, product segments, and demographics. We are also recognized for delivering significant returns on investment through our comprehensive data collection at affordable prices.

Contacts

Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: media@technavio.com
Website: www.technavio.com/

Read News Read Less
Interested in this report?
Get your sample now!

Safe and Secure SSL Encrypted

Technavio

  • 2500 USD

[5 reports/month/user]

  • 5000 USD

close
  • Basic Plan [5000 USD/Year]:

    Single User
    Download 5 Reports/Month
    View 100 Reports/Month
    Add upto 3 Users at 625 USD/user

  • Teams Plan [7500 USD/Year]:

    5 User
    Download 5 Reports/Month/User
    View 100 Reports/Month/User
    Add upto 30 Users at 500 USD/user

*You can upgrade to Teams plan at Subscription page

close
  • Single:

    One user only.
    Quick & easy download option

  • Enterprise:

    Unlimited user access (Within your organization).
    Complimentary Customization Included

*For Enterprise license, go to checkout page

Technavio Get the report (PDF) sent to your email within minutes.